WallStreetZenWallStreetZen

NASDAQ: TNGX
Tango Therapeutics Inc Stock Ownership - Who owns Tango Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Tango Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Third Rock Ventures Iv LP10% Owner2024-02-20162,500$12.00
$1.95MSell
Adam CrystalPresident Research Development2024-02-074,083$12.62
$51.53kSell
Douglas BarryGeneral Counsel2024-02-071,354$12.62
$17.09kSell
Daniella BeckmanChief Financial Officer2024-02-071,817$12.62
$22.93kSell
Barbara WeberChief Executive Officer2024-02-074,457$12.62
$56.25kSell
Douglas BarryGeneral Counsel2024-02-061,422$12.56
$17.86kSell
Daniella BeckmanChief Financial Officer2024-02-061,908$12.56
$23.97kSell
Adam CrystalPresident Research Development2024-02-064,288$12.56
$53.87kSell
Barbara WeberChief Executive Officer2024-02-064,681$12.56
$58.81kSell
Adam CrystalPresident Research Development2023-11-017,507$8.39
$62.99kSell

1 of 2

TNGX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNGX insiders and whales buy or sell their stock.

TNGX Shareholders

What type of owners hold Tango Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Trv GP Iv LLC18.14%19,363,975$141.55MInstitution
Third Rock Ventures Iv LP17.99%19,201,475$140.36MInsider
Boxer Capital LLC14.23%15,187,092$111.02MInsider
Ecor1 Capital LLC12.49%13,330,736$97.45MInsider
Ecor1 Capital LLC12.49%13,330,736$97.45MInstitution
Fmr LLC9.17%9,787,350$71.55MInstitution
Boxer Capital LLC7.68%8,198,642$59.93MInstitution
Aaron I. Davis6.55%6,993,450$51.12MInsider
Bctg Holdings LLC6.55%6,988,450$51.09MInsider
Nextech Invest Ltd5.19%5,533,980$40.45MInstitution

1 of 3

TNGX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNGX59.42%40.58%Net BuyingNet Selling
RLAY72.36%27.64%Net SellingNet Selling
SAGE71.61%28.39%Net Selling
SPRY43.85%56.15%Net BuyingNet Buying
PLRX70.74%29.26%Net Selling
View Top Biotech Stocks

Tango Therapeutics Stock Ownership FAQ

Who owns Tango Therapeutics?

Tango Therapeutics (NASDAQ: TNGX) is owned by 87.75% institutional shareholders, 59.93% Tango Therapeutics insiders, and 0.00% retail investors. Third Rock Ventures Iv LP is the largest individual Tango Therapeutics shareholder, owning 19.20M shares representing 17.99% of the company. Third Rock Ventures Iv LP's Tango Therapeutics shares are currently valued at $140.36M.

If you're new to stock investing, here's how to buy Tango Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.